A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.

NCT00077766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

313

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Darbepoetin alfa
DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche